News

Community-Acquired MRSA Hit L.A. Children


 

WASHINGTON — A clonal outbreak of community-acquired methicillin-resistant Staphylococcus aureus in Los Angeles County led to a high rate of hospitalizations among children in 2003, Elizabeth Bancroft, M.D., reported in a poster at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy.

Following four skin infection outbreaks due to a particular clone of MRSA (USA 300; ST:8) in 2002, the Los Angeles County Department of Health Services made community-acquired methicillin-resistant S. aureus (CAMRSA) infections in hospitalized children less than 18 years of age a reportable condition for 6 months during 2003. A total of 140 cases were reported between May 5 and Nov. 7, said Dr. Bancroft of the county health department.

Mean age of the children was 6.25 years (range 0-17), 51% were female, 66% were Hispanic, 16% white, 15% black, and the remainder said they were “other.” Their mean length of stay was 5.13 days (range 1-30). Diagnoses included cellulitis in 44%, abscess in 36%, and a combination of the two in 11%.

In 23%, chart notes indicated a misdiagnosis of possible insect or spider bites, and 75% of the total 135 who had been treated with antibiotics were initially treated inappropriately with β-lactams, she said at the conference, sponsored by the American Society for Microbiology.

Among 82 for whom a caregiver was interviewed, 24 (29%) had a household contact with a skin infection within a month of the child's infection.

Other nosocomial risk factors were present in 29 (35%), while risk factors for community-acquired infection were present in 38 (46%), including 9 (11%) who had contact with a recently incarcerated person.

Of 83 isolates analyzed, 79 (96%) were consistent with the USA 300; ST:8 CAMRSA genotype, even though many of the children had nosocomial risk factors. During the 6 months, the 140 pediatric CAMRSA cases in Los Angeles far outnumbered other common reportable diseases, including salmonella (99) and invasive pneumococcal disease (84), she noted.

Recommended Reading

Comment on "Recalcitrant Tinea Corporis as the Presenting Manifestation of Patch-Stage Mycosis Fungoides" (Cutis. 2003;71:59-61)[letter]
MDedge Dermatology
Therapeutic Options for Herpes Labialis, I: Oral Agents
MDedge Dermatology
Therapeutic Options for Herpes Labialis, II: Topical Agents
MDedge Dermatology
Over-the-Counter Topical Skin Products—A Common Component of Skin Disease Management
MDedge Dermatology
Effectiveness of Imiquimod Cream 5% for Treating Childhood Molluscum Contagiosum in a Double-blind, Randomized Pilot Trial
MDedge Dermatology
Coombs-Positive Hemolytic Anemia Secondary to Brown Recluse Spider Bite: A Review of the Literature and Discussion of Treatment
MDedge Dermatology
Systemic Manifestations and Treatment of Brown Recluse Spider Bites [editorial]
MDedge Dermatology
What Is Your Diagnosis? Cutaneous Leishmaniasis
MDedge Dermatology
Comment on "Therapeutic Options for Herpes Labialis, II: Topical Agents" (Cutis. 2004;74:35-40)[letter]
MDedge Dermatology
Gianotti-Crosti Syndrome Following Milkers' Nodules
MDedge Dermatology